EISSN 2979-9139

FORMERLY: TURKISH THORACIC JOURNAL SCOPUS CITESCORE: 1.5 OPEN ACCESS NO APCs INDEXED IN: PUBMED CENTRAL INDEXED IN: WEB OF SCIENCE AND SCOPUS

Thoracic Research and Practice

25 243 2024

HIGHLY CITED ARTICLES

Chronic Pulmonary Diseases and COVID-19

By: Edis, EC

Turkish Thoracic Society Experts Consensus Report: Recommendations for Pulmonary Function Tests During and After COVID 19 Pandemic

By: Gemicioglu, B; Borekci, S; Dilektasli, AG; et al.

Health Hazards and Complications Associated with Electronic Cigarettes: A Review

By: Gulsen, A and Uslu, B

Validity and Reliability of the Turkish Version of the London Chest Activity of Daily Living Scale in Obstructive Lung Diseases

By: Saka, S; Savci, S; Kutukcu, EC; et al.

Which Screening Questionnaire is Best for Predicting Obstructive Sleep Apnea in the Sleep Clinic Population Considering Age, Gender, and Comorbidities?

By: Arslan, BO; Hosgor, ZZU and Orman, MN

Prevalence of Zinc Deficiency and the Effect of Zinc Supplementation on the Prevention of Acute Respiratory Infections

By: Khera, D; Singh, S; Purohit, P; et al.

Pulmonary Embolism in Covid-19: Coagulation Parameters, Close Monitoring to Prevent?

By: Annunziata, A; Imitazione, P; Polistina, GE; et al.

Self-Management Training in Chronic Obstructive Lung Disease Improves the Quality of Life

By: Ozturk, BO; Alpaydin, AO; Ozalevli, S; et al.

Evidence Based Treatment of SARS-CoV2: A Narrative Review

By: Agrawal, S; Gupta, N and Goel, AD

What We Learned about COVID-19 So Far? Notes from Underground

By: Akyil, FT; Karadogan, D; Gurkan, CG; et al.

MOST READ ARTICLES

Examining Visfatin As a New Sarcoidosis Biomarker

Tanrıverdi et al.

Patients with Large-Cell Neuroendocrine Carcinoma

Çırak et al.

Asthma, Preoperative Risk Assessment

Erdoğan et al.

Short Communication

COVID-19 Pandemic Action Plan of a University Hospital

Nur Yapar ¹ , Eyüp Sabri Uçan ² , Fırat Bayraktar ³ , Necati Gökmen ⁴ , Arzu Sayıner ⁵ , Ziya Kuruüzüm ¹ , Başak Bayram ⁶ , Sema Alp Çavuş ¹ , Oğuz Kılınç ² , Vildan Avkan Oğuz ¹ , Yusuf Savran ³ , Semih Küçükgüçlü ⁷ , Murat Celiloğlu ⁸

Author Affiliation(s)

1.

Department of Infectious Diseases and Clinical Microbiology, Dokuz Eylül University School of Medicine, İzmir, Turkey

2.

Department of Respiratory Medicine, Dokuz Eylül University School of Medicine, İzmir, Turkey

3.

Department of Internal Medicine, Dokuz Eylül University School of Medicine, İzmir, Turkey

4.

Department of Anesthesiology and Reanimation, Intensive Care Unit, Dokuz Eylül University School of Medicine, İzmir, Turkey

5.

Department of Medical Microbiology, Dokuz Eylül University School of Medicine, İzmir, Turkey

6.

Department of Emergency Medicine, Dokuz Eylül University School of Medicine, İzmir, Turkey

7.

Head of Hospital Administration, Dokuz Eylül University School of Medicine, İzmir, Turkey

8.

Dean of Medical Faculty, Dokuz Eylül University School of Medicine, İzmir, Turkey

Thorac Res Pract 2021; 22: 95-98

DOI: 10.5152/TurkThoracJ.2021.20141

Keywords : Pandemic, severe acute respiratory syndrome coronavirus 2, new coronavirus, coronavirus disease 2019, action plan

Read: 1097 Downloads: 505 Published: 01 January 2021

Volume 22, Issue 1, January 2021

Previous Article

In December 2019, in Wuhan, China, scientists observed a sudden and sharp increase in the number of cases of pneumonia and acute respiratory distress syndrome of an unknown origin. By the end of January 2020, the outbreak had spread to Asia, Europe, America, and Australia. In this article, we have outlined the pandemic action plan of our university hospital.

Cite this article as: Yapar N, Uçan ES, Bayraktar F, et al. COVID-19 pandemic action plan of a university hospital. Turk Thorac J 2021; 22(1): 95-8.

Files